Proposed
Bill · 119th Congress · HR 10857
To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.
Refreshed 1 h ago
Introduced 2026-10-22Summary
No summary yet. The official text is available on Congress.gov.
Sponsors
- Jake Auchincloss Democrat sponsor
- 1 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-10-22 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2026-10-22 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2026-10-22 | Introduced in House | introduce | |
| 2026-10-22 | Introduced in House | introduce |